Menu
Back to Journals » Biologics: Targets and Therapy » Volume 2 » Issue 1
Biologics: Targets and Therapy
ISSN: 1177-5491
- View all (491)
- Volume 17, 2023 (12)
- Volume 16, 2022 (18)
- Volume 15, 2021 (40)
- Volume 14, 2020 (13)
- Volume 13, 2019 (17)
- Volume 12, 2018 (19)
- Volume 11, 2017 (14)
- Volume 10, 2016 (18)
- Volume 9, 2015 (17)
- Volume 8, 2014 (27)
- Volume 7, 2013 (28)
- Volume 6, 2012 (46)
- Volume 5, 2011 (9)
- Volume 4, 2010 (31)
- Volume 3, 2009 (45)
- Volume 2, 2008 (89)
- Volume 1, 2007 (48)
Archive: Volume 2, 2008
The potential role of curcumin (diferuloylmethane) in plasma cell dyscrasias/paraproteinemia
Terry Golombick, Terry Diamond
Biologics: Targets and Therapy 2008, 2:161-163
Published Date: 7 March 2008
Activity of the lipoxygenase inhibitor 1-phenyl-3-pyrazolidinone (phenidone) and derivatives on the inhibition of adhesion molecule expression on human umbilical vascular endothelial cells
Torsten Hans Schroeder, Wolfgang Artur Krueger, Hans-Jürgen Dieterich, Boris Nohé
Biologics: Targets and Therapy 2008, 2:151-160
Published Date: 7 March 2008
Garlic compounds selectively kill childhood pre-B acute lymphoblastic leukemia cells in vitro without reducing T-cell function: Potential therapeutic use in the treatment of ALL
Greg Hodge, Stephen Davis, Michael Rice, Heather Tapp, Ben Saxon, Tamas Revesz
Biologics: Targets and Therapy 2008, 2:143-149
Published Date: 7 March 2008
Pitfalls, prevention, and treatment of hyperuricemia during tumor lysis syndrome in the era of rasburicase (recombinant urate oxidase)
Andrea Pession, Fraia Melchionda, Claudia Castellini
Biologics: Targets and Therapy 2008, 2:129-141
Published Date: 7 March 2008
The PRECiSE 2 trial of certolizumab pegol, a new PEGylated anti-TNF agent, in the treatment of Crohn's disease - An interview with David A Schwartz, 13 June 2007
David A Schwartz
Biologics: Targets and Therapy 2008, 2:125-128
Published Date: 7 March 2008
Infliximab for the treatment of plaque psoriasis
Jennifer S Gall, Robert E Kalb
Biologics: Targets and Therapy 2008, 2:115-124
Published Date: 7 March 2008
Cervarix™: a vaccine for the prevention of HPV 16, 18-associated cervical cancer
Archana Monie, Chien-Fu Hung, Richard Roden, T-C Wu
Biologics: Targets and Therapy 2008, 2:107-113
Published Date: 7 March 2008
Sunitinib for advanced renal cell cancer
Chris Coppin
Biologics: Targets and Therapy 2008, 2:97-105
Published Date: 7 March 2008
Erlotinib in the treatment of advanced pancreatic cancer
Robin K Kelley, Andrew H Ko
Biologics: Targets and Therapy 2008, 2:83-95
Published Date: 7 March 2008
Review of tocilizumab in the treatment of rheumatoid arthritis
Yasuaki Okuda
Biologics: Targets and Therapy 2008, 2:75-82
Published Date: 7 March 2008
Current and future applications of the anti-IgE antibody omalizumab
Cristoforo Incorvaia, Marina Mauro, Gian Galeazzo Riario-Sforza, Franco Frati, Francesco Tarantini, Maurizio Caserini
Biologics: Targets and Therapy 2008, 2:67-73
Published Date: 7 March 2008
Lapatinib in combination with capecitabine in the management of ErbB2-positive (HER2-positive) advanced breast cancer
Bella Kaufman, Steven Stein, Michelle A Casey, Beth O Newstat
Biologics: Targets and Therapy 2008, 2:61-65
Published Date: 7 March 2008
Bevacizumab in the therapy for refractory metastatic colorectal cancer
Mary F Mulcahy
Biologics: Targets and Therapy 2008, 2:53-59
Published Date: 7 March 2008
Alemtuzumab in the treatment of fludarabine refractory B-cell chronic lymphocytic leukemia (CLL)
Marco Montillo, Francesca Ricci, Sara Miqueleiz, Alessandra Tedeschi, Enrica Morra
Biologics: Targets and Therapy 2008, 2:41-52
Published Date: 7 March 2008
Abciximab: a reappraisal of its use in coronary care
Marco Valgimigli, Gianluca Campo, Matteo Tebaldi, Roberto Carletti, Chiara Arcozzi, et al
Biologics: Targets and Therapy 2008, 2:29-39
Published Date: 7 March 2008
Clinical uses of GM-CSF, a critical appraisal and update
Martha Arellano, Sagar Lonial
Biologics: Targets and Therapy 2008, 2:13-27
Published Date: 7 March 2008
A review of becaplermin gel in the treatment of diabetic neuropathic foot ulcers
Robert C Fang, Robert D Galiano
Biologics: Targets and Therapy 2008, 2:1-12
Published Date: 7 March 2008